Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the completed ABP 654 plaque psoriasis study, including its design, eligibility criteria, locations, outcomes, and supporting documents.SummaryDifference97%

- Check20 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.3%

- Check27 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision marker changed from v3.7.0 to v3.7.1, while the page remains a 403 error screen.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating the study record is currently inaccessible on the site.SummaryDifference19%

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.